[Anti-HMG-CoA reductase necrotizing myopathy: A report of 4 cases].
CONCLUSION: An early diagnosis of this myopathy is necessary in order to introduce an immunotherapy associated with a close monitoring. The therapeutic strategy (within which the stead of intravenous immunoglobulin seems increased) remains to be defined and long-term prospective studies are thus needed.
PMID: 27876175 [PubMed - as supplied by publisher]
Source: Revue de Medecine Interne - Category: Internal Medicine Tags: Rev Med Interne Source Type: research
More News: Cardiology | Cholesterol | Corticosteroid Therapy | Heart | Immunotherapy | Internal Medicine | Methotrexate | Respiratory Medicine | Statin Therapy | Study | Toxicology